Methods of detecting factor D with anti-factor D antibodies
US8753826B2 · kind B2 · utility
7Cited by
41References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 5, 2013 |
| Grant date | Jun 17, 2014 |
| Priority date | — |
| Expiry date | Feb 5, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to humanized anti-human Factor D monoclonal antibodies, their nucleic acid and amino acid sequences, the cells and vectors that harbor these antibodies and their use in the preparation of compositions and medicaments for treatment of diseases and disorders associated with excessive or uncontrolled complement activation. These antibodies are useful for diagnostics, prophylaxis and treatment of disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.